Long-term results of surgical techniques and procedures in men with benign prostatic hyperplasia

被引:7
|
作者
Metcalfe C. [1 ]
Poon K.S. [1 ]
机构
[1] Department of Urologic Sciences, University of British Columbia, Richmond, BC V7C 5L9
关键词
Adverse effects; Benign prostatic hyperplasia; Bladder neck contracture; BPH; CLP; Contact laser prostatectomy; HoLAP; HoLEP; Humans; Hybrid techniques; Induced necrosis; Laser therapy; Male; Methods; Minimally invasive methods; Mortality; Open simple prostatectomy; OSP; Photoselective vaporization of the prostate; Physiopathology; Postoperative complications; Prostate; Prostatectomy; PVP; Surgery; Surgical procedures; Transurethral holmium laser ablation of the prostate; Transurethral holmium laser enucleation of the prostate; Transurethral microwave thermotherapy; Transurethral needle ablation of the prostate; Transurethral resection of prostate; Transurethral vaporization of the prostate; Treatment outcome; TUMT; TUNA; TURP; TUVP;
D O I
10.1007/s11934-011-0193-1
中图分类号
学科分类号
摘要
Benign prostatic hyperplasia (BPH) is one of the most common conditions associated with the aging male. Surgical management of lower urinary tract symptoms attributed to BPH has progressed over time as urologic surgeons search for more innovative and less invasive forms of treatment. Transurethral resection of the prostate (TURP) has long been the "gold standard" to which all other forms of treatment are compared. There are several different methods of surgical treatment of BPH, including whole gland enucleation/intact removal, vaporization, and induction of necrosis with delayed reabsorption as well as hybrid techniques. As with any form of surgical intervention, long-term results define success. Long-term follow-up consists of examining overall efficacy with attention to associated adverse events. TURP has the luxury of the longest follow-up, while less invasive forms of treatment starting to acquire long-term data. There are several surgical options for BPH; newer methods do show promise, while the "gold standard" continues to demonstrate excellent surgical results. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码:265 / 273
页数:8
相关论文
共 50 条
  • [11] The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia
    Rachael L. DiSantostefano
    Andrea K. Biddle
    John P. Lavelle
    PharmacoEconomics, 2006, 24 : 171 - 191
  • [12] PATTERNS OF LONG-TERM FINASTERIDE USE FOR BENIGN PROSTATIC HYPERPLASIA
    Cruz, Alan Paniagua
    Annis, Ann
    Chrouser, Kristin
    Skolarus, Ted
    JOURNAL OF UROLOGY, 2020, 203 : E706 - E706
  • [13] Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia
    Ichioka, K
    Ohara, H
    Terada, N
    Matsui, Y
    Yoshimura, K
    Terai, A
    Arai, Y
    INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (10) : 870 - 875
  • [14] Experience of Long-Term Afala Treatment in Benign Prostatic Hyperplasia
    A. V. Gudkov
    Bulletin of Experimental Biology and Medicine, 2009, 148
  • [15] Experience of Long-Term Afala Treatment in Benign Prostatic Hyperplasia
    Gudkov, A. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 148 (02) : 308 - 311
  • [16] Alfuzosin for symptomatic benign prostatic hyperplasia: Long-term experience
    McVary, KT
    JOURNAL OF UROLOGY, 2006, 175 (01): : 35 - 42
  • [17] Long-term dutasteride therapy results in continued improvements in symptoms and peak urinary flow in men with symptomatic benign prostatic hyperplasia
    Roehrborn, CG
    Marks, LS
    Fenter, T
    Barkin, J
    Freedman, S
    Gittelman, M
    JOURNAL OF UROLOGY, 2004, 171 (04): : 242 - 242
  • [18] Long-term results of Wallstent implantation in benign prostatic hyperplasia and in high-risk groups
    Goepel, M
    Senge, A
    Otto, T
    Rubben, H
    UROLOGE-AUSGABE A, 1997, 36 (02): : 151 - 156
  • [19] Long-term results of Wllstent implantation in benign prostatic hyperplasia and in high-risk groups
    M. Goepel
    A. Senge
    T. Otto
    H. Rübben
    Der Urologe A, 1997, 36 : 151 - 156
  • [20] Novel surgical techniques for treatment of benign prostatic hyperplasia
    Schoeb, D. S.
    Reichelt, A. C.
    Gross, A. J.
    Abt, D.
    Miernik, A.
    Gratzke, C.
    UROLOGE, 2020, 59 (03): : 347 - 358